文献速递免疫规划慢病防控与筛查

美国糖尿病患者乙型肝炎疫苗接种覆盖情况(2018年)

Hepatitis B Vaccination Among Adults With Diabetes Mellitus, U.S., 2018.
PubMed 文献 · Am J Prev Med · 2021-07-20

该研究基于2014-2018年美国国家健康访谈调查数据,评估18-59岁及≥60岁糖尿病成人的乙肝疫苗系列完成率(≥3剂)。2018年18-59岁糖尿病患者覆盖率为33.2%,较2014年上升9.7个百分点(p<0.05);≥60岁患者覆盖率为15.3%,2014-2018年无增长。糖尿病患者与非糖尿病患者覆盖率无显著差异。

要点

  • 2018年18-59岁糖尿病成人乙肝疫苗覆盖率为33.2%,较2014年上升9.7个百分点。
  • ≥60岁糖尿病成人2018年覆盖率仅15.3%,2014-2018年无增长。
  • 糖尿病患者与非糖尿病患者乙肝疫苗覆盖率无显著差异。

核心结论

  • 糖尿病患者自报乙肝疫苗接种覆盖率仍不理想。
  • 医务人员应评估患者糖尿病状态,推荐并提供所需疫苗或转介接种。

研究设计与样本

  • 分析2014-2018年美国国家健康访谈调查数据,评估18-59岁和≥60岁糖尿病成人乙肝疫苗系列完成(≥3剂)情况。
  • 采用多变量logistic回归分析识别与接种独立相关的因素。

主要发现

  • 2018年18-59岁糖尿病成人中33.2%已接种乙肝疫苗(≥3剂),较2014年上升9.7个百分点(p<0.05)。
  • ≥60岁糖尿病成人2018年覆盖率为15.3%,2014-2018年期间未增加。
  • 控制评估因素后,糖尿病患者与非糖尿病患者覆盖率无显著差异。
  • 在18-59岁和≥60岁糖尿病成人中,较年轻年龄、具有大学教育、曾接受HIV检测、为医务人员或曾前往乙肝病毒流行区与接种可能性增加独立相关。

关键数值与推荐

  • 乙肝疫苗接种常规推荐用于<60岁糖尿病成人,≥60岁者由医务人员酌情决定。
  • 疫苗系列完成定义为≥3剂。

临床怎么用

  • 医务人员应评估患者糖尿病状态,推荐并提供所需疫苗接种,或转介至其他接种点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hepatitis B vaccination is routinely recommended for adults with diabetes mellitus aged <60 years and for those aged ≥60 years at the discretion of their healthcare provider. The purpose of this study is to assess hepatitis B vaccination coverage among adults with and without diabetes mellitus. METHODS: Data from the 2014-2018 National Health Interview Survey were analyzed in 2020 to determine hepatitis B vaccination series completion (≥3 doses) among adults aged 18-59 and ≥60 years with diabetes mellitus. Multivariable logistic regression analysis was conducted to identify the factors independently associated with hepatitis B vaccination among adults aged 18-59 and ≥60 years with diabetes mellitus. RESULTS: In 2018, among adults aged 18-59 years with diabetes mellitus, 33.2% had received hepatitis B vaccination (≥3 doses), an increase of 9.7 percentage points from 2014 (p<0.05). Among adults aged ≥60 years with diabetes mellitus, coverage was 15.3% in 2018 and did not increase during 2014-2018. Coverage was not significantly different among adults with diabetes mellitus compared with those without diabetes mellitus, even after controlling for the assessed factors. Among adults with diabetes mellitus aged 18-59 and ≥60 years, younger age, having some college or college education, having been tested for HIV, being healthcare personnel, or having traveled to hepatitis B virus-endemic areas were independently associated with an increased likelihood of vaccination. CONCLUSIONS: Self-reported hepatitis B vaccination coverage among adults with diabetes mellitus remains suboptimal. Healthcare providers should assess patients' diabetes status, recommend and offer needed vaccinations to patients, or refer them to alternate sites for vaccination.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Lu PJ, Hung MC, Srivastav A, et al. Hepatitis B Vaccination Among Adults With Diabetes Mellitus, U.S., 2018. Am J Prev Med. 2021. PMID: 34294463. doi:10.1016/j.amepre.2021.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。